medicalxpress.com
How to reduce the number of colonoscopies and improve follow-up for patients with Crohn's disease
Frequent routine colonoscopies after Crohn's surgery are invasive and burdensome. Using fecal calprotectin for regular monitoring could reduce unnecessary colonoscopies and detect recurrence earlier when inflammation is rising.
Adults with Crohn's disease who have had ileocolonic resection, gastroenterologists and IBD clinics, and caregivers involved in postoperative follow-up.
What To Know
Researchers followed more than 50 patients after ileocolonic resection and tracked stool calprotectin over several years. They report that patients with consistently low calprotectin had no detected lesions, and their protocol used repeat stool testing when levels rose above 250 μg/g and reserved colonoscopy when levels exceeded 400 μg/g.
The authors and their hospital have begun using this calprotectin-based monitoring strategy, and the article says the approach was recently included in European IBD guideline recommendations. This study suggests using regular fecal calprotectin tests to catch post-operative recurrence earlier without repeating routine colonoscopies for every patient.
In practice, the team used specific calprotectin cutoffs to trigger repeat stool testing and to decide when to perform colonoscopy. Their hospital has implemented the approach for follow-up after the first annual post-op colonoscopy.
Practical points: fecal calprotectin is a noninvasive stool test that can reflect intestinal inflammation and is presented here as a tool to monitor patients after ileocolonic resection. The article summarizes a single research group's prospective experience over several years and notes alignment with recent European guideline recommendations.
If you want more detail, read the original paper in Digestive and Liver Disease to see study size, exact methods, and limitations.
This report describes a prospective study from a single research group and implementation at their hospital; check the original Digestive and Liver Disease paper and guidelines for details before changing care. Calprotectin thresholds and monitoring schedules can vary across studies and guideline panels.
